메뉴 건너뛰기




Volumn 353, Issue 9169, 1999, Pages 2001-2007

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

(352)  Hjalmarson, A a   Goldstein, S a   Fagerberg, B a,b   Wedel, H a   Waagstein, F a   Kjekshus, J a   Wikstrand, J a   Westergren, G a   Thimell, M a   El Allaf, D a   Vitovec J a   Aldershvile, J a   Halinen, M a   Dietz, R a   Neuhaus, K L a   Janosi A a   Thorgeirsson, G a   Dunselman, P a   Gullestad, L a   Kuch, J a   more..


Author keywords

[No Author keywords available]

Indexed keywords

METOPROLOL; PLACEBO;

EID: 0033549290     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)04440-2     Document Type: Article
Times cited : (4650)

References (29)
  • 1
    • 0033590646 scopus 로고    scopus 로고
    • Consensus recommendations for the management of chronic heart failure
    • Consensus recommendations for the management of chronic heart failure. Am J Cardiol. 83:1999;2-38A.
    • (1999) Am J Cardiol , vol.83
  • 2
    • 0028955321 scopus 로고
    • Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure
    • Garg R.G., Yusuf S. Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 273:1995;1450-1456.
    • (1995) JAMA , vol.273 , pp. 1450-1456
    • Garg, R.G.1    Yusuf, S.2
  • 3
    • 0025913812 scopus 로고
    • Effect of enalapril on survival in patients with reduced left ventricular ejections fraction and congestive heart failure
    • Effect of enalapril on survival in patients with reduced left ventricular ejections fraction and congestive heart failure. N Engl J Med. 325:1991;293-302.
    • (1991) N Engl J Med , vol.325 , pp. 293-302
  • 4
    • 0026786643 scopus 로고
    • Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial
    • Pfeffer M.A., Braunwald E., Moyé L.A.et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med. 327:1992;669-677.
    • (1992) N Engl J Med , vol.327 , pp. 669-677
    • Pfeffer, M.A.1    Braunwald, E.2    Moyé, L.A.3
  • 5
    • 0016701034 scopus 로고
    • Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy
    • Waagstein F., Hjalmarson Å., Varnauskas X., Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 37:1975;1022-1036.
    • (1975) Br Heart J , vol.37 , pp. 1022-1036
    • Waagstein, F.1    Hjalmarson, Å.2    Varnauskas, X.3    Wallentin, I.4
  • 6
    • 0018759507 scopus 로고
    • Prolongation of survival in congestive cardiomyopathy by β-receptor blockade
    • Swedberg K., Hjalmarson Å., Waagstein F., Wallentin I. Prolongation of survival in congestive cardiomyopathy by β-receptor blockade. Lancet. i:1979;1374-1376.
    • (1979) Lancet , vol.1 , pp. 1374-1376
    • Swedberg, K.1    Hjalmarson, Å.2    Waagstein, F.3    Wallentin, I.4
  • 7
    • 0020578830 scopus 로고
    • Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction
    • Gundersen T. Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction. Br Heart J. 50:1983;135-139.
    • (1983) Br Heart J , vol.50 , pp. 135-139
    • Gundersen, T.1
  • 8
    • 0022613443 scopus 로고
    • Effect of propranolol after acute myocardial infarction in patients with congestive heart failure
    • Chadda K., Goldstein S., Byington R., Curb J.D. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation. 73:1986;503-510.
    • (1986) Circulation , vol.73 , pp. 503-510
    • Chadda, K.1    Goldstein, S.2    Byington, R.3    Curb, J.D.4
  • 9
    • 0027135308 scopus 로고
    • Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
    • Waagstein F., Bristow M.R., Swedberg K.et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 342:1993;1441-1446.
    • (1993) Lancet , vol.342 , pp. 1441-1446
    • Waagstein, F.1    Bristow, M.R.2    Swedberg, K.3
  • 10
    • 0028092116 scopus 로고
    • A randomized trial of β-blockade in heart failure: The cardiac insufficiency bisoprolol study (CIBIS)
    • A randomized trial of β-blockade in heart failure: the cardiac insufficiency bisoprolol study (CIBIS). Circulation. 90:1994;1765-1773.
    • (1994) Circulation , vol.90 , pp. 1765-1773
  • 11
    • 0029937949 scopus 로고    scopus 로고
    • The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
    • Packer M., Bristow M.R., Cohn J.N.et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
    • (1996) N Engl J Med , vol.334 , pp. 1349-1355
    • Packer, M.1    Bristow, M.R.2    Cohn, J.N.3
  • 12
    • 0031050642 scopus 로고    scopus 로고
    • Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
    • Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet. 349:1997;375-380.
    • (1997) Lancet , vol.349 , pp. 375-380
  • 13
    • 0001415097 scopus 로고    scopus 로고
    • Metoprolol prevents left ventricular dilatation and increase exercise ejection fraction to the same extent in idiopathic and ischemic cardiomyopathy
    • abstr
    • Waagstein F., Wahlqvist I., Andersson B.et al. Metoprolol prevents left ventricular dilatation and increase exercise ejection fraction to the same extent in idiopathic and ischemic cardiomyopathy. Eur Heart J. 19(suppl):1998;307. abstr.
    • (1998) Eur Heart J , vol.19 , Issue.SUPPL , pp. 307
    • Waagstein, F.1    Wahlqvist, I.2    Andersson, B.3
  • 14
    • 0030668967 scopus 로고    scopus 로고
    • Rationale, design, and organisation of the metoprolol CR/XL randomized trial in heart failure (MERIT-HF)
    • Rationale, design, and organisation of the metoprolol CR/XL randomized trial in heart failure (MERIT-HF). Am J Cardiol. 80:1997;54-58J.
    • (1997) Am J Cardiol , vol.80
  • 15
    • 0029793162 scopus 로고    scopus 로고
    • Mode of death in chronic heart failure. a request and proposition for more accurate classification
    • Narang R., Cleland J.G.F., Erhardt L.et al. Mode of death in chronic heart failure. a request and proposition for more accurate classification. Eur Heart J. 17:1996;1390-1403.
    • (1996) Eur Heart J , vol.17 , pp. 1390-1403
    • Narang, R.1    Cleland, J.G.F.2    Erhardt, L.3
  • 17
    • 0030941991 scopus 로고    scopus 로고
    • Effects of beta-blocker therapy on mortality in patients with heart failure
    • Doughty R.N., Rodgers A., Sharpe N., MacMahon S. Effects of beta-blocker therapy on mortality in patients with heart failure. Eur Heart J. 18:1997;560-565.
    • (1997) Eur Heart J , vol.18 , pp. 560-565
    • Doughty, R.N.1    Rodgers, A.2    Sharpe, N.3    MacMahon, S.4
  • 18
    • 0030738423 scopus 로고    scopus 로고
    • Effect of beta-blockade on mortality in patients with heart failure: A meta-analysis of randomized clinical trials
    • Heydenrich P.A., Lee T.T., Massie B.M. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 30:1997;27-34.
    • (1997) J Am Coll Cardiol , vol.30 , pp. 27-34
    • Heydenrich, P.A.1    Lee, T.T.2    Massie, B.M.3
  • 19
    • 0033514046 scopus 로고    scopus 로고
    • The cardiac insufficiency bisoprolol study II (CIBIS II)
    • The cardiac insufficiency bisoprolol study II (CIBIS II). Lancet. 353:1999;9-13.
    • (1999) Lancet , vol.353 , pp. 9-13
  • 20
    • 0006735145 scopus 로고    scopus 로고
    • Arrhytmias and sudden death in heart failure: Can we prevent them?
    • J.J.V. McMurray, & J.G.F. Cleland. London: Martin Dunitz Ltd
    • Rankin A.C., Cobbe S.M. Arrhytmias and sudden death in heart failure: can we prevent them? McMurray J.J.V., Cleland J.G.F. Heart failure in clinical practice. 1996;189-205 Martin Dunitz Ltd, London.
    • (1996) Heart Failure in Clinical Practice , pp. 189-205
    • Rankin, A.C.1    Cobbe, S.M.2
  • 21
    • 0026501035 scopus 로고
    • Metoprolol-induced reduction in postinfarction mortality: Pooled results from five double-blind randomized trials
    • Olsson G., Wikstrand J., Warnold I.et al. Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J. 13:1992;28-32.
    • (1992) Eur Heart J , vol.13 , pp. 28-32
    • Olsson, G.1    Wikstrand, J.2    Warnold, I.3
  • 22
    • 0026083132 scopus 로고
    • Primary prevention of sudden cardiovascular death in hypertensive patients: Mortality results from the MAPHY study
    • Olsson G., Tuomilehto J., Berglund G.et al. Primary prevention of sudden cardiovascular death in hypertensive patients: mortality results from the MAPHY study. Am J Hypertens. 4:1991;151-158.
    • (1991) Am J Hypertens , vol.4 , pp. 151-158
    • Olsson, G.1    Tuomilehto, J.2    Berglund, G.3
  • 23
    • 0026699315 scopus 로고
    • The role of beta receptor blockade in preventing sudden death
    • Wikstrand J., Kendall M. The role of beta receptor blockade in preventing sudden death. Eur Heart J. 13(suppl D):1992;111-120.
    • (1992) Eur Heart J , vol.13 , Issue.SUPPL. D , pp. 111-120
    • Wikstrand, J.1    Kendall, M.2
  • 24
    • 0032757563 scopus 로고    scopus 로고
    • Extended release metoprolol CR/XL in patients with heart failure: A pilot study examining the tolerability, safety and effect on left ventricular ejection fraction
    • in press
    • Goldstein S., Kennedy H.L., Hall C.et al. Extended release metoprolol CR/XL in patients with heart failure: a pilot study examining the tolerability, safety and effect on left ventricular ejection fraction. Am Heart J. 1999;. in press.
    • (1999) Am Heart J
    • Goldstein, S.1    Kennedy, H.L.2    Hall, C.3
  • 25
    • 0032542884 scopus 로고    scopus 로고
    • 3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial
    • 3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial. Lancet. 351:1998;1180-1181.
    • (1998) Lancet , vol.351 , pp. 1180-1181
  • 26
    • 0023931531 scopus 로고
    • Design of a new multiple-unit controlled-release formulation of metoprolol: Metoprolol CR/XL
    • Sandberg A., Ragnarsson G., Jonsson U.E., Sjögren J. Design of a new multiple-unit controlled-release formulation of metoprolol: metoprolol CR/XL. Eur J Clin Pharmacol. 33(suppl):1988;S3-7.
    • (1988) Eur J Clin Pharmacol , vol.33 , Issue.SUPPL , pp. 3-7
    • Sandberg, A.1    Ragnarsson, G.2    Jonsson, U.E.3    Sjögren, J.4
  • 27
    • 0000843285 scopus 로고    scopus 로고
    • The effect on heart rate of immediate and slow-release metoprolol in patients with chronic heart failure
    • abstr
    • Andersson B., Åberg J. The effect on heart rate of immediate and slow-release metoprolol in patients with chronic heart failure. J Am Coll Cardiol. 33:1999;183-184A. abstr.
    • (1999) J Am Coll Cardiol , vol.33
    • Andersson, B.1    Åberg, J.2
  • 28
    • 0030698868 scopus 로고    scopus 로고
    • Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (A subgroup analysis of the Göteborg Metoprolol Trial)
    • Herlitz J., Waagstein F., Lindqvist J., Swedberg K., Hjalmarson Å. Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (A subgroup analysis of the Göteborg Metoprolol Trial). Am J Cardiol. 80:1997;40-44J.
    • (1997) Am J Cardiol , vol.80
    • Herlitz, J.1    Waagstein, F.2    Lindqvist, J.3    Swedberg, K.4    Hjalmarson, Å.5
  • 29
    • 0032930518 scopus 로고    scopus 로고
    • Similar risk reducing effect of extended release metoprolol once daily and immediate release metoprolol twice daily during 5 years after myocardial infarction
    • in press
    • Herlitz J., Dellborg M., Karlson B.W.et al. Similar risk reducing effect of extended release metoprolol once daily and immediate release metoprolol twice daily during 5 years after myocardial infarction. Cardiovasc Drugs Ther. 1999;. in press.
    • (1999) Cardiovasc Drugs Ther
    • Herlitz, J.1    Dellborg, M.2    Karlson, B.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.